Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation
Article in Human Immunology (June 2024)
The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.
Article in Human Immunology (June 2024)
Article in ACS Infectious Diseases (June 2024)
Article in International Journal of Biological Macromolecules (April 2024)